High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis

Journal of Translational Medicine
Adil MaaroufSophie Desplat-Jégo

Abstract

Inflammation and demyelination are the main processes in multiple sclerosis. Nevertheless, to date, blood biomarkers of inflammation are lacking. TWEAK, a transmembrane protein that belongs to the TNF ligand family, has been previously identified as a potential candidate. Twenty-eight patients (9 males, 19 females) were prospectively included after a first clinical episode suggestive of multiple sclerosis and clinically followed during 3 years. Fifty-seven healthy controls were also included. TWEAK serum levels and MRI exams including magnetization transfer imaging were performed at baseline, 6- and 12-month follow-up. TWEAK serum levels were significantly increased in the patient group (mean baseline = 1086 ± 493 pg/mL, mean M6 = 624 ± 302 pg/mL and mean M12 = 578 ± 245 pg/mL) compared to healthy controls (mean = 467 ± 177 pg/mL; respectively p < 0.0001, 0.01 and 0.06). Serum levels of soluble TWEAK were significantly increased during relapses, compared to time periods without any relapse (respectively 935 ± 489 pg/mL and 611 ± 292 pg/mL, p = 0.0005). Moreover, patients presenting at least one gadolinium-enhanced CNS lesion at baseline (n = 7) displayed significantly increased serum TWEAK levels in comparison with patients wit...Continue Reading

References

Mar 1, 1992·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·H B Larsson, P S Tofts
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Nov 1, 1995·Annals of Neurology·W BrückH Lassmann
Jan 1, 1995·Acta Neuropathologica·W BrückR L Friede
Nov 1, 1994·Journal of Neuropathology and Experimental Neurology·E E Kwon, J W Prineas
Sep 1, 1993·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·S J KarlikJ H Noseworthy
Dec 1, 1996·Acta Neurologica Scandinavica·R LiebschB Conrad
Jan 24, 1998·The Journal of Biological Chemistry·Y ChicheporticheJ L Browning
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
Mar 20, 1999·The Journal of Biological Chemistry·C N LynchS R Wiley
May 29, 2000·Brain : a Journal of Neurology·A BitschW Brück
Nov 26, 2002·Journal of Neuroimmunology·Sophie Desplat-JégoJosé Boucraut
Feb 26, 2003·Neurology·Francois CottonCharles R G Guttmann
Apr 2, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Se-Hwa KimWon-Ha Lee
Sep 7, 2004·Annals of Neurology·Klaus SchmiererDavid H Miller
Jul 20, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Sophie Desplat-JégoJosé Boucraut
Nov 4, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rohini PolavarapuManuel Yepes
Jul 13, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Xiaohui ZhangManuel Yepes
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stuart J PerperHenry Hess
Mar 29, 2007·Brain Pathology·Hans LassmannClaudia F Lucchinetti
Jul 13, 2007·International Journal of Injury Control and Safety Promotion·L Laflamme, M Vaez
Oct 24, 2008·Journal of Leukocyte Biology·Sophie Desplat-JégoJosé Boucraut
Nov 20, 2008·Journal of Neuropathology and Experimental Neurology·Barbara SerafiniFrancesca Aloisi
Mar 10, 2011·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Mar 24, 2012·Lancet Neurology·Massimo FilippiUNKNOWN Attendees of the Correlation between Pathological MRI findings in MS workshop
Jun 21, 2012·Nature Reviews. Neuroscience·Peter K StysJeroen J G Geurts
Jan 17, 2013·Journal of Neuroinflammation·Delphine StephanSophie Desplat-Jégo
Apr 13, 2013·Journal of Autoimmunity·Jing WenChaim Putterman
Jan 9, 2014·Frontiers in Immunology·Ariel D StockChaim Putterman
Jan 11, 2014·Frontiers in Immunology·Daniel BertinSophie Desplat-Jégo
May 30, 2014·Neurology·Fred D LublinChris H Polman
Mar 6, 2015·Radiology·Robert J McDonaldLaurence J Eckel
Mar 17, 2015·Lancet Neurology·Don H MahadHans Lassmann
Apr 23, 2015·Brain : a Journal of Neurology·Mar TintoreXavier Montalban
Oct 11, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Adil MaaroufJean-Philippe Ranjeva
Jan 14, 2017·Nature Reviews. Neurology·Maria TrojanoHelmut Butzkueven

❮ Previous
Next ❯

Citations

Aug 14, 2020·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Faruk KiliçArif Demirdaş

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

JMP
ImCalc
GraphPad
SPM12
GraphPad PRISM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.